CompanyIntelligence | MacroChem Corp.

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$33	Subscribers Preview	2001	Callable Warrant	MacroChem Corp.
$37	Subscribers Preview	2004	Common Stock Purchase Warrant	MacroChem Corp.
$41	Subscribers Preview	2003	Common Stock Purchase Warrant	MacroChem Corp.
$37	Subscribers Preview	2004	Confidentiality Agreement	Glenn Deegan	MacroChem Corp.
$38	Subscribers Preview	1997	Equity Incentive Plan [1994]	MacroChem Corp.
$44	Subscribers Preview	2002	Executive Employee Agreement	Dennis R. Fowler	MacroChem Corp.
$35	Subscribers Preview	2001	Incentive Plan [2001]	MacroChem Corp.
$40	Subscribers Preview	2001	Key Employee Agreement	Thomas C. K. Chan	MacroChem Corp.
$38	Subscribers Preview	2001	Key Employee Agreement	Bernard Patriacca	MacroChem Corp.
$42	Subscribers Preview	2001	Key Employee Agreement	Mel Snyder	MacroChem Corp.
$36	Subscribers Preview	2003	Letter Agreement	IBEX Technologies Inc.; Robert J. DeLuccia	MacroChem
$38	Subscribers Preview	2001	Letter Agreement	Robert J. Palmisano	MacroChem Corp.
$38	Subscribers Preview	2003	Letter Agreement Re: Retention Benefit	Bernard R. Patriacca	MacroChem Corp.
$40	Subscribers Preview	2003	Letter Agreement Re: Retention Benefit	Melvin A. Snyder	MacroChem Corp.
$31	Subscribers Preview	2003	Letter Agreement Re: Retention Benefit	Thomas C. K. Chan	MacroChem Corp.
$34	Subscribers Preview	2003	Letter Agreement Re: Retention Benefit	Glenn E. Deegan	MacroChem Corp.
$39	Subscribers	2003	MacroChem Announces $3.25 Million Private Placement	MacroChem Corp.
$35	Subscribers	2004	MacroChem Announces $7.29 Million Private Placement with Institutional Investors	MacroChem Corp.	JMP Securities LLC
$36	Subscribers	2003	MacroChem Announces Departure of CEO Robert Palmisano & Appointment of Board Member Robert J. Deluccia as Vice Chairman & Interim CEO	Immunomedics, Inc.	MacroChem Corp.
$33	Subscribers	2004	MacroChem Announces Preliminary Phase 2 Results for Topiglan(R), Its Topically Applied Erectile Dysfunction Product	MacroChem Corp.